The Office of the Attorney General for the District of Columbia is investigating DaVita, one of the largest dialysis providers in the country, and its ties to the nonprofit American Kidney Fund.
DaVita disclosed the new “civil investigative demand” in its latest annual financial filing to investors. The D.C. attorney general is specifically looking at “communications with AKF, documents relating to donations to the AKF, and communications with patients, providers, and insurers regarding the AKF.” The probe covers everything from January 2016 to the present day. DaVita’s competitor, Fresenius, similarly disclosed it received a subpoena from the D.C. attorney general’s office.
DaVita said in the filing it “is cooperating with the government in this investigation.” A DaVita spokesperson added in a statement that the D.C. attorney general’s subpoena “focuses on the handful of clinics within D.C. We aim to obtain a swift resolution of this inquiry into a relationship that was previously investigated by the Department of Justice and found to be compliant with the law.”
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect